Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Safety profile of crizanlizumab 5.0 mg/kg in sickle cell disease: pooled data from clinical trials

2025Journal of sickle cell disease.JournalOpen access

10.1093/jscdis/yoaf036 Full text0 citations

Authors

14 authors across 15 institutions in 6 countries.

Abdullah KutlarFirst authorCorresponding
Vikas Joshi
Andreas Brueckner
Julie Kanter
Darla K. Liles
as printed: Darla Liles
Jeremie Lincy
Rahul Manjare
Yvonne Dei‐Adomakoh
- Korle Bu Teaching Hospital (GH)
as printed: Yvonne Dei-Adomakoh
Michele L Nassin
as printed: Michele Nassin
Matthew M. Heeney
as printed: Matthew M Heeney
Mariane de Montalembert
Deborah Keefe
as printed: Deborah Lynn Keefe
Kwaku Marfo
Kenneth I AtagaSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Hemoglobinopathies and Related Disorderslevel 3 · 0.99
Biosimilars and Bioanalytical Methodslevel 3 · 0.00
Myeloproliferative Neoplasms: Diagnosis and Treatmentlevel 3 · 0.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 5, 2026
2025 · Journal of sickle cell disease. · 0 citations
https://openalex.org/W4416222401

Safety profile of crizanlizumab 5.0 mg/kg in sickle cell disease: pooled data from clinical trials · Sankore